Bliss GVS Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 191 | 155.80 | 172.28 |
| Operating Expense | 157.27 | 122.22 | 179.75 |
| Net Profit | 17.04 | 19.42 | -11.46 |
| Net Profit Margin | 8.92 | 12.46 | -6.65 |
| Earning Per Share | 1.63 | 1.85 | -1.11 |
| EBIDTA | 35.62 | 33.88 | 2.29 |
| Effective Tax Rate | 25.91 | 20.94 | -80.19 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 191.00 |
| Operating Expense | 157.27 |
| Net Profit | 17.04 |
| Net Profit Margin | 8.92 |
| Earning Per Share | 1.63 |
| EBIDTA | 35.62 |
| Effective Tax Rate | 25.91 |
Invest in Bliss GVS Pharma Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 605.46 | 598.34 | 636.36 |
| Operating Expenses Annual | 498.29 | 508.18 | 527.16 |
| Operating Profit Annual | 99.58 | 140.92 | 144.57 |
| Interest Annual | 5.81 | 10.06 | 4.32 |
| Depreciation | 23.52 | 15.17 | 13.85 |
| Net Profit Annual | 50.64 | 85.48 | 92.66 |
| Tax Annual | 19.61 | 30.21 | 33.74 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 605.46 |
| Operating Expenses Annual | 498.29 |
| Operating Profit Annual | 99.58 |
| Interest Annual | 5.81 |
| Depreciation | 23.52 |
| Net Profit Annual | 50.64 |
| Tax Annual | 19.61 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 18.60 | 13.82 | 4.67 |
| Cash Flow from Operations | 125.92 | 43.81 | 114.05 |
| Cash Flow from Investing | -109.59 | -12.97 | -92.28 |
| Cash Flow from Financing | -20.76 | -26.05 | -12.62 |
| Cash Flow at the End | 14.17 | 18.60 | 13.82 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 18.60 |
| Cash Flow from Operations | 125.92 |
| Cash Flow from Investing | -109.59 |
| Cash Flow from Financing | -20.76 |
| Cash Flow at the End | 14.17 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 23.18 | 23.55 | 22.72 |
| PBIT Margin (%) | 19.29 | 21.02 | 20.54 |
| PBT Margin (%) | 15.97 | 18.93 | 15.78 |
| Net PROFIT Margin (%) | 8.36 | 14.29 | 14.56 |
| Return On Networth / Equity (%) | 7.91 | 9.56 | 11.53 |
| Return On Networth /Employed (%) | 11.19 | 12.81 | 14.59 |
| Return On Assets (%) | 4.85 | 8.71 | 10.34 |
| Total Debt / Equity (X) | 0.08 | 0.10 | 0.11 |
| Asset Turnover Ratio (%) | 0.58 | 0.61 | 0.71 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 23.18 |
| PBIT Margin (%) | 19.29 |
| PBT Margin (%) | 15.97 |
| Net PROFIT Margin (%) | 8.36 |
| Return On Networth / Equity (%) | 7.91 |
| Return On Networth /Employed (%) | 11.19 |
| Return On Assets (%) | 4.85 |
| Total Debt / Equity (X) | 0.08 |
| Asset Turnover Ratio (%) | 0.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 329.95 | 324.82 | 224.31 |
| Total Current Assets Annual | 772.98 | 729.65 | 791.74 |
| Non Current Assets Annual | 379.57 | 410.04 | 288.22 |
| Total Shareholders Funds Annual | 988.44 | 937.00 | 851.43 |
| Total Assets Annual | 1,152.55 | 1,139.69 | 1,079.96 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 329.95 |
| Total Current Assets Annual | 772.98 |
| Non Current Assets Annual | 379.57 |
| Total Shareholders Funds Annual | 988.44 |
| Total Assets Annual | 1,152.55 |
EPS (INR)
Expected
2.31
Reported
2.31
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
